Indigestion drug makes headway | Science News



Support credible science journalism.

Subscribe to Science News today.


Indigestion drug makes headway

10:28am, March 7, 2006

Functional dyspepsia is the diagnosis that doctors often assign to people with chronic indigestion who don't have a stomach ulcer or clear signs of acid-reflux disease. These people have a sense of fullness even though they haven't eaten much, and they have bloating, nausea, and stomach pain that can resemble heartburn. The cause of functional dyspepsia is unclear, and standard medications offer little help.

Researchers report in the Feb. 23 New England Journal of Medicine that a drug called itopride relieves symptoms of functional dyspepsia significantly better than a placebo does.

Physician Gerald Holtmann of the Royal Adelaide Hospital in Australia and his colleagues randomly assigned 554 volunteers with functional dyspepsia to receive one of three dosages of itopride or a similar-looking inert pill.

After 8 weeks, 60 percent of the people getting itopride and 41 percent of those on the placebo reported improvement in their symptoms.

Itopride bin

This article is available only to subscribing members. Join the Society today or Log in.

Get Science News headlines by e-mail.

More from this issue of Science News

From the Nature Index Paid Content